Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Speeding towards individualized treatment for pancreatic cancer by taking an alternative road.

Cancer letters - 1 Dec 2017

Iovanna Juan, Dusetti Nelson

Abstract excerpt

Accumulation of genetic mutations drives the development of pancreatic ductal adenocarcinoma (PDAC). Contrary to what it is expected, however, genetic analyses, no matter how precise or detailed, do not allow the identification of patient groups with different clinical outcomes or the selection of specific treatments. In fact, clinical outcome and sensitivity to treatments are associated with a given phenotype...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Carcinoma, Pancreatic Ductal
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pancreatic Neoplasms

Share to Patient Selection

Share to Precision Medicine

Share to Predictive Value of Tests

Share to Transcriptome

Source

Identifiers

PMID: 28947138
DOI: 10.1016/j.canlet.2017.09.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Speeding towards individualized treatment for pancreatic cancer by taking an alternative road.PMID 28947138Read ↗

Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancerSemantic proximity Read ↗

Pancreatic cancer organoids derived from EUS-guided fine needle aspiration specimens can be used to predict chemotherapy resistance.Semantic proximity Read ↗

Deep molecular characterization linked to drug response profiling of pancreatic ductal adenocarcinoma using patient-derived organoidsSemantic proximity Read ↗

Personalising pancreas cancer treatment: When tissue is the issue.Semantic proximity Read ↗

The Promise of Epigenomic Therapeutics in Pancreatic CancerSemantic proximity Read ↗

Pancreatic cancer: from genes to patient care.Semantic proximity Read ↗

Evidence for the Importance of Personalized Molecular Profiling in Pancreatic CancerSemantic proximity Read ↗

Expression analysis of pancreatic cancer cell lines reveals association of enhanced gene transcription and genomic amplifications at the 8q22.1 and 8q24.22 loci.Semantic proximity Read ↗

Basic principles and technologies for deciphering the genetic map of cancer.Semantic proximity Read ↗

Will Organoids Fill the Gap towards Functional Precision Medicine?Semantic proximity Read ↗

A new platform for gene discovery in pancreatic cancer.Semantic proximity Read ↗

Genome-wide transcriptome profiling of ex-vivo precision-cut slices from human pancreatic ductal adenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.